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Abstract Nerve growth factor (NGF), basic fibroblast growth 
factor (bFGF), dibutyryl cAMP and forskolin, known differ-
entiating agents for pheochromocytoma PCI 2 cells, induced 
sustained activation of sphingosine kinase, the enzyme respon-
sible for the formation of the sphingolipid second messenger, 
sphingosine-1-phosphate, which mediates the mitogenic effects of 
certain growth factors. In contrast, epidermal growth factor and 
insulin-like growth factor-1, which stimulate proliferation of 
PCI 2 cells, induced only small and transient increases in 
sphingosine kinase activity. Of the growth factors examined, 
NGF was the most potent activator of sphingosine kinase, 
inducing a 4-fold increase in Fmax. Sphingosine kinase activity 
induced by NGF, but not FGF, was blocked by the protein kinase 
inhibitor K252a when added simultaneously, with minimal effect 
when added after 60 min. Thus, activation of sphingosine kinase 
may have an important role in neural differentiation. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Given the complexity and extreme cellular diversity of the 
nervous system, the study of transformed neural crest-derived 
cell lines, such as rat pheochromocytoma PC 12 cells which 
recapitulate many of growth and neurotrophic factor signal-
ing events, has been instrumental in understanding the mech-
anisms of neuronal differentiation and proliferation [1-3]. 
Although binding of NGF and EGF to their respective cell 
surface receptors stimulates similar signal transduction cas-
cades, NGF induces neurite outgrowth and neural markers, 
and cessation of cell growth, whereas EGF only stimulates 
proliferation [1,4]. It has been suggested that in neurons, dis-
crimination between strong/prolonged and weak/transient ac-
tivation of the extracellular signal regulated kinase (ERK) 
signaling pathway may be the cause of these opposite effects 
[4]. However, other studies indicate that this might be a more 
complex process, and other pathways are also probably in-
volved [2,3]. 
Intermediates in biosynthesis and catabolism of sphingolip-
ids, ceramide, sphingosine and SPP, have recently been impli-
cated in intracellular signaling important for neuronal surviv-
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al, differentiation, development, and death [5-9]. Because 
increased levels of ceramide were observed during differentia-
tion of neuroblastoma Neuro2a cells and SH-SY5Y cells [5,6], 
it has been suggested that ceramide plays a role in neuronal 
differentiation. Moreover, inhibitors of ceramide biosynthesis, 
such as fumonisin Bl, interfere with differentiation of Neu-
ro2a and cerebellar granule cells [6], and cultured hippocam-
pal neurons [10]. However, increased ceramide levels within 
distal neurites inhibits neurite growth of cultured rat sympa-
thetic neurons [7] and of NGF-differentiated PC 12 cells [11]. 
Similarly, sphingosine, a metabolite of ceramide, suppresses 
NGF-directed neurite outgrowth in PC12 cells [12], likely by 
conversion to ceramide. The role of the further metabolite of 
sphingosine, SPP, produced by activation of sphingosine kin-
ase, which generally provides positive signals for cell growth 
and survival [13-15], has not been established in neurons. 
Recently, SPP has been shown to play a distinct role in alter-
ing neuronal cell morphology [9,16] and stimulation of the 
ERK signaling pathway in diverse cell types [13,17,18], remi-
niscent of effects elicited upon growth factor stimulation. Fur-
thermore, it has been suggested that the intracellular ratio of 
ceramide to SPP may be a critical factor in determining the 
fate of cells [13]. In this report, we examined the effects of 
diverse trophic agents on sphingosine kinase activity in PC 12 
cells. Our results suggest that sustained activation of sphingo-
sine kinase may be important for neurotrophic responses. 
2. Materials and methods 
2.1. Materials 
Mouse 2.5S nerve growth factor was obtained from Upstate Bio-
technology; bFGF was purchased from Promega; EGF, IGF-1 and 
insulin were purchased from Collaborative Research; dibutyryl cAMP 
was from Boehringer Mannheim; sphingosine was purchased from 
Matreya; SPP was from Biomol. 
2.2. Cell culture 
Rat PC12 pheochromocytoma cells were kindly provided by Dr. 
Gordon Guroff (NICHD, NIH, Bethesda, MD). Cells were grown 
on polystyrene tissue culture dishes in RPMI 1640 medium supple-
mented with 10% heat-inactivated horse serum and 5% fetal calf se-
rum (Gibco), plus 100 units/ml penicillin and 100 ug/ml streptomycin 
(Biofluids). Cells were seeded, except where indicated, at a density of 
5 X 104/cm2 and allowed to grow for 2-4 days before experiments were 
performed. All experiments, unless otherwise described, were con-
ducted after 3 day exposure to NGF. At this time, long processes 
and other morphological changes were clearly observed. Cells were 
maintained in a 37°C incubator in 5% CO2, water-saturated atmos-
phere. 
2.3. Sphingosine kinase activity 
Sphingosine kinase activity was measured as previously described 
[19]. Briefly, after treatment, cells were washed twice with PBS and 
harvested in kinase buffer (20 mM Tris buffer (pH 7.4) containing 
20% glycerol, 1 mM P-mercaptoethanol, 1 mM EDTA, 15 mM 
NaF, 20 mM Na3V04, 1 mM MgCl2, 0.5 mM 4-deoxypyridoxine, 
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1 mM PMSF, 10 ng/ml leupeptin, and 10 ug/ml aprotinin). After 
freeze-thawing three times, cytosolic extracts were obtained by centrif-
ugation for 10 min at 14000Xg. 20-50 u,g protein was used in each 
kinase assay. Reactions were started by addition of 250 uM 
[y-32P]ATP (3000 Ci/mmol, ICN) and 50 uM sphingosine in a final 
volume of 100 ill. Samples were incubated at 37°C for 10 min and 
reactions were terminated with 10 u.1 of 1 N HCl followed by 400 u.1 of 
chloroform/mefhanol/HCl (100:200:1, v/v). After vortexing, 125 ul 
each of 2 M KC1 and chloroform were added for phase separation. 
Lipids in the chloroform phase were resolved on silica gel 60 thin 
layer chromatography plates (EM Science) in butanol/ethanol/acetic 
acid/water (80:20:10:20, v/v). SPP was visualized by autoradiography, 
scraped from the plates and measured by liquid scintillation counting. 
For preparation of cytosolic and particulate fractions, cells were re-
suspended in kinase buffer, freeze-thawed three times, and centrifuged 
at lOOOOOXgfor 60 min. 
2.4. Measurement of SPP levels 
After 2 days of NGF treatment, cells were labeled for the final 24 
hours of NGF exposure with 32Pi (40 mCi/ml, ICN), in the presence 
of 0.5 mM 4-deoxypyridoxine to inhibit pyridoxal phosphate-depend-
ent SPP aldolase. The media was removed and 1 ml of 0.1 N HCl and 
4 ml of chloroform :methanol (2:1, v/v) were added to extract the 
lipids. The lipids in the organic phase were separated by two-dimen-
sional TLC: chloroform/methanol/water (66:33:8, v/v) in the first 
dimension; and 1-butanol/methanol/acetic acid/ water (80:20:10:20, 
v/v) in the second dimension [15]. Standard SPP and sphingosine 
were applied with the samples and lipids were visualized with iodine 
vapors or by spraying with ninhydrin. The major cellular lipids and 
sphingolipids were excised from the plate and counted by liquid scin-
tillation [15], 
2.5. Protein measurement 
Protein measurements were performed following the procedure of 
Bradford with the Coomassie Plus Protein Assay Reagent (Pierce). 
3. Results and discussion 
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3.1. Activation of sphingosine kinase by prolonged treatment 
with NGF 
Treatment of PC 12 cells with NGF for 3 days, which causes 
differentiation and expression of neurofilament protein, mark-
edly activated sphingosine kinase (Fig. 1A). Concomitantly, 
levels of SPP, the product of sphingosine kinase action, were 
increased 2.8-fold. After prolonged treatment of NGF for up 
to 2 weeks, sphingosine kinase activity remained markedly 
elevated (up to 5-6-fold). Activation of sphingosine kinase 
by NGF was dose-dependent, with maximal activation occur-
ring at 100 ng/ml (Fig. IB). Sphingosine kinase activity in 
extracts of untreated PC 12 cells, as well as in cells treated 
with NGF, exhibited typical Michaelis-Menten kinetics, with 
a 4-fold increase in Vmax induced by NGF without a signifi-
cant change in the Km for sphingosine (Fig. 1C). In a wide 
variety of cells and tissues, sphingosine kinase activity has 
been found to be present mainly in the cytosol (reviewed in 
Table 1 
Distribution of spli 
Treatment 
Cytosol 
Particulate 
ingosine kinase in PC 12 cells 
Sphingosine kinase activity 
None NGF 
9.6 ±0.3 25.0 ±0.7 
2.7 ±0.2 4.8 ±0.2 
Fold increase 
2.6 
1.8 
Sphingosine kinase activity in cytosol and particulate fractions of 
PC 12 cells was determined before and after treatment of PC 12 with 
NGF (100 ng/ml) for 3 days. Sphingosine kinase activity is expressed 
as pmol/min/mg protein. Data are the means ± S.D. of triplicate cell 
cultures. Similar results were obtained in two independent experi-
ments. 
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Fig. 1. Effect of NGF on sphingosine kinase activity. A: NGF acti-
vates sphingosine kinase. PC12 cells were treated with NGF (100 
ng/ml) for the indicated times and sphingosine kinase activity was 
measured as described in Section 2. B: Dose response. PC12 cells 
were treated with the indicated concentrations of NGF for 3 days 
and sphingosine kinase activity was measured. C: Michaelis-Menten 
kinetics. Cells were treated in the absence (closed circles) or pres-
ence of NGF (open circles) for 3 days and cytosolic sphingosine 
kinase activity was determined in the presence of increasing concen-
trations of sphingosine. All data are expressed as fold increase in 
sphingosine kinase activity and are the mean ± S.D. of triplicate cul-
tures. Similar results were obtained in five independent experiments. 
[14]). However, membrane-bound forms of sphingosine kinase 
have also been detected [20,21]. In PC12 cells, the majority of 
sphingosine kinase activity is located in the cytoplasm and 
NGF treatment increased the activity to a similar extent in 
both cytoplasmic and particulate fractions (Table 1). 
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Fig. 2. Involvement of trkA in NGF activation of sphingosine kin-
ase. A: K252a inhibits NGF induced sphingosine kinase. Sphingo-
sine kinase activity in PC 12 cells stimulated with bFGF (20 ng/ml) 
or NGF (100 ng/ml) for 3 days was determined in the absence or 
presence of K252a (200 nM). Data are the mean ± S.D. of fold in-
creases in kinase activity. Similar results were obtained in two inde-
pendent experiments. B: Time course of K252a inhibition of NGF-
induced increase in sphingosine kinase activity. PC12 cells were 
treated with NGF (100 ng/ml) at 0 time and K252a (200 nM) was 
added at the indicated time points after addition of NGF. Sphingo-
sine kinase activity was measured after 3 days and is expressed as 
percent of the activity in untreated cells. Data are the means ± S.D. 
of triplicate cultures, and similar results were obtained in two inde-
pendent experiments. 
3.2. Activation of sphingosine kinase by NGF occurs through 
the trkA receptor 
Most of the actions of NGF are mediated by binding to the 
trkA receptor resulting in the dimerization of the receptor and 
autophosphorylation of key tyrosine residues [1-4,22]. Due to 
the potent activation of sphingosine kinase in response to 
NGF treatment, we investigated whether trkA mediated acti-
vation of sphingosine kinase. K252a, an inhibitor of trkA [23], 
completely blocked the activation of sphingosine kinase in-
duced by NGF after 3 days of treatment (Fig. 2A), indicating 
that the trkA receptor is essential for NGF-induced sphingo-
sine kinase activation. In contrast, K252a had no effect on 
activation of sphingosine kinase induced by bFGF or on basal 
sphingosine kinase activity. TrkA activation and subsequent 
autophosphorylation of key tyrosine residues has been shown 
to occur within minutes of neurotrophin binding and quickly 
attenuates thereafter [22]. Inhibition of the activation of 
sphingosine kinase by NGF was observed only when K252a 
was added within the first 30 min of exposure to NGF, with a 
minimal effect resulting when added after 60 min (Fig. 2B). 
3.3. Long-term activation of sphingosine kinase by NGF 
requires protein synthesis and is dependent on cell density 
Sustained elevation of sphingosine kinase activity induced 
by chronic treatment with NGF suggested that NGF is likely 
stimulating synthesis of sphingosine kinase protein. Treatment 
of PC 12 cells with the protein synthesis inhibitor cyclohexi-
mide dramatically reduced the extent of NGF-stimulated 
sphingosine kinase activity, indicating that the observed in-
crease in Fmax was due to an increase in enzyme concentration 
(Fig. 3A). The effects of NGF on sphingosine kinase activity 
were also dependent on cell density, since increasing the cell 
density produced a corresponding increase in NGF-induced 
sphingosine kinase activation (Fig. 3B). Thus, cell-cell contact 
may be important for some of the trophic effects of NGF in 
PC12 cells. 
Cell density (105/cm2) 
Fig. 3. Protein synthesis is required for NGF-induced sustained acti-
vation of sphingosine kinase. A: Effect of cycloheximide. PC12 cells 
were treated with cycloheximide (10 ug/ml) with and without the 
presence of NGF (100 ng/ml) and sphingosine kinase activity was 
measured. B: Effect of cell density. PC12 cells were plated at the in-
dicated densities, in the absence (open circles) or presence of NGF 
(closed circles). Sphingosine kinase activity is expressed as pmol/ 
min/mg protein and all values are the mean ± S.D. of triplicate cul-
tures. 
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Fig. 4. Effect of various growth factors on sphingosine kinase activ-
ity in PC 12 cells. A: Cells were treated for the indicated times with 
NGF (100 ng/ml; open circles), EGF (100 ng/ml; open squares), 
IGF-1 (100 nM; open triangles), bFGF (20 ng/ml, closed circles) 
and sphingosine kinase activity was measured. B: Cells were treated 
with NGF (100 ng/ml), dibutyryl cAMP (1 mM), forskolin (10 uM), 
TPA (100 nM), insulin (100 nM), IGF-1 (100 nM), EGF (100 ng/ 
ml), KC1 (50 mM) and dexamethasone (100 nM) and sphingosine 
kinase activity was measured after 3 days. All data are the 
mean ± S.D. of fold increases in kinase activity. Similar results were 
obtained in three independent experiments. 
3.4. Effects of neurotrophic factors on sphingosine kinase 
activity in PC12 cells 
It was of interest to examine whether other growth factors 
and trophic agents besides NGF could also affect sphingosine 
kinase in PC12 cells. Similar to NGF, bFGF also induced a 
biphasic increase in sphingosine kinase activity, although the 
magnitude of the response was smaller (Fig. 4A). In contrast, 
other mitogens, including EGF and IGF-1, induced only 
small and transient increases. Although treatment of PC12 
cells for 3 days with TPA, insulin, IGF-1, or EGF did not 
have any effect on sphingosine kinase activity, dibutyryl 
cAMP and forskolin, which promote survival [24] and differ-
entiation of neuronal cells [25], significantly activated sphin-
gosine kinase to similar levels observed after exposure to 
bFGF, but all were less effective than NGF (Fig. 4B). Thus, 
agents that promote both survival and differentiation of PC 12 
cells were the most effective activators of sphingosine kinase. 
Studies of events mediating neuronal cell homeostasis indi-
cate that a variety of neurotrophin-induced, receptor-medi-
ated events can influence the type of biological responses pro-
duced. Our findings suggest that activation of sphingosine 
kinase, the enzyme responsible for the production of the sec-
ond messenger SPP, correlates with the neurotrophic effects of 
NGF and bFGF on PC12 cells. Subtle differences in signaling 
pathways mediated by distinct production of second messen-
gers, such as SPP, may modulate intrinsic cellular homeosta-
sis. Thus, activation of sphingosine kinase may help fine-tune 
responses to the many signals a cell receives and aid in medi-
ating cellular events leading to proliferation, differentiation, 
or apoptosis. 
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